bioRxivBioinformaticsPreprint
In Silico Investigations of Adaptive Therapy Using Two Cytotoxic or Two Cytostatic Drugs
Daniel K. SahaiD, Alexander R.A. AndersoniD, Luis Humberto CisnerosiD, Carlo C. MaleyiD
Abstract
While the dose modulation (DM) protocols (DM Cocktail Tandem, DM Ping-Pong Alternate Every Cycle, DM Ping-Pong on Progression) involves adjusting drug dosages when the tumor burden changes, the fixed-dose (FD) protocols involves administering a specific, constant dosage of the drug only when the tumor is growing (Dose-Skipping) or when the absolute tumor burden is above the baseline level until it reduces to a certain percentage of the baseline (Intermittent). Moreover, two different drugs can be administered simultaneously (cocktail), or the drugs can be switched such that only one drug is applied at a given time (ping-pong), either every cycle (ping-pong alternate every cycle) or when the tumor grows (ping-pong on progression). The dose modulation protocols work well when treated with two cytotoxic drugs, however, the ping-pong protocols (DM Ping-Pong Alternate Every Cycle, DM Ping-Pong on Progression, FD Ping-Pong Intermittent) work well when treated with two cytostatic drugs. In general, adaptive therapy, using either two cytotoxic or two cytostatic drugs works best under conditions of high competition, such as high fitness cost, high replacement rates, and high turnover, although treatment using two cytostatic drugs works best under low turnover in many cases. Adaptive therapy works best when drug dosages are changed as soon as a change in tumor burden is detected, and it is best to pause treatment sooner rather than later when the tumor is shrinking. Adaptive therapy works best when an intermediate level of drug dosage is used, and both treatment with too little or too much drug leads to poor survival outcome.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In Silico Investigations of Adaptive Therapy Using a Single Cytotoxic or a Single Cytostatic Drug
Daniel K. Saha, Alexander R.A. Anderson, … Carlo C. Maley·bioRxiv·May 14, 2023
- A Mathematical Framework for Comparison of Intermittent and Continuous Adaptive Chemotherapy Dosing in Cancer
Cordelia D. McGehee, Yoichiro Mori A·npj Systems Biology and ApplicationsPeer-reviewed·Nov 29, 2024
- Towards multi-drug adaptive therapy
J. West, L. You, … A. R. Anderson·bioRxiv·Jul 25, 2019
- Modifying adaptive therapy to enhance competitive suppression
E. Hansen, A. F. Read·bioRxiv·Oct 26, 2020
- Optimizing adaptive cancer therapy: dynamic programming and evolutionary game theory
M. Gluzman, J. G. Scott, A. Vladimirsky·bioRxiv·Dec 10, 2018
- On the design and stability of cancer adaptive therapy cycles: deterministic and stochastic models
Yuri Garcia Vilela, Artur C. Fassoni, A. G. M. Neves·Mathematical BiosciencesPeer-reviewed·Jul 16, 2025